Search Results

There are 4542 results for: content related to: Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: A case report

  1. You have free access to this content
    Mirtazapine versus other antidepressive agents for depression

    Intervention Review

    The Cochrane Library

    Norio Watanabe, Ichiro M Omori, Atsuo Nakagawa, Andrea Cipriani, Corrado Barbui, Rachel Churchill and Toshi A Furukawa

    Published Online : 7 DEC 2011, DOI: 10.1002/14651858.CD006528.pub2

  2. You have free access to this content
    Mirtazapine: only for depression?

    Acta Neuropsychiatrica

    Volume 18, Issue 3-4, June/August 2006, Pages: 130–143, Luis San and Belen Arranz

    Version of Record online : 21 SEP 2006, DOI: 10.1111/j.1601-5215.2006.00143.x

  3. Pharmacokinetics of Mirtazapine: Enantioselective Effects of the CYP2D6 Ultra Rapid Metabolizer Genotype and Correlation with Adverse Effects

    Clinical Pharmacology & Therapeutics

    Volume 81, Issue 5, May 2007, Pages: 699–707, J Brockmöller, I Meineke and J Kirchheiner

    Version of Record online : 28 FEB 2007, DOI: 10.1038/sj.clpt.6100116

  4. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2-adrenergic and serotonin2C receptors: a comparison with citalopram

    European Journal of Neuroscience

    Volume 12, Issue 3, March 2000, Pages: 1079–1095, M. J. Millan, A. Gobert, J. -M. Rivet, A. Adhumeau-Auclair, D. Cussac, A. Newman-Tancredi, A. Dekeyne, J. -P. Nicolas and F. Lejeune

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1460-9568.2000.00982.x

  5. You have free access to this content
    Ameliorating effects of mirtazapine on visceral hypersensitivity in rats with neonatal colon sensitivity

    Neurogastroenterology & Motility

    Volume 22, Issue 9, September 2010, Pages: 1022–e267, J. Yin, W. Wang, J. H. Winston, R. Zhang and J. D. Z. Chen

    Version of Record online : 26 MAY 2010, DOI: 10.1111/j.1365-2982.2010.01526.x

  6. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial

    International Journal of Clinical Practice

    Volume 65, Issue 3, March 2011, Pages: 323–329, J. E. Kim, S. J. Yoon, J. Kim, J. Y. Jung, H. S. Jeong, H. B. Cho, E. Shin, I. K. Lyoo and T. S. Kim

    Version of Record online : 14 FEB 2011, DOI: 10.1111/j.1742-1241.2010.02624.x

  7. Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study


    Francisca M. Scoralick, Luciana L. Louzada, Juliana L. Quintas, Janeth O.S. Naves, Einstein F. Camargos and Otávio T. Nóbrega

    Version of Record online : 27 JAN 2016, DOI: 10.1111/psyg.12191

  8. You have free access to this content
    Influence of Mirtazapine on the Hypotensive Activity of Enalapril and Propranolol in Spontaneously Hypertensive Rats

    Basic & Clinical Pharmacology & Toxicology

    Volume 103, Issue 5, November 2008, Pages: 450–454, Dariusz Andrzejczak, Katarzyna Kocon and Remigiusz Zięba

    Version of Record online : 11 AUG 2008, DOI: 10.1111/j.1742-7843.2008.00310.x

  9. A fast, sensitive and simple method for mirtazapine quantification in human plasma by HPLC-ESI-MS/MS. Application to a comparative bioavailability study

    Biomedical Chromatography

    Volume 26, Issue 11, November 2012, Pages: 1399–1407, Ney Carter Borges, Rafael Eliseo Barrientos-Astigarraga, Carlos Eduardo Sverdloff, José Luiz Donato, Patricia Moreno, Leila Felix, Paulo Alexandre Rebelo Galvinas and Ronilson Agnaldo Moreno

    Version of Record online : 16 FEB 2012, DOI: 10.1002/bmc.2711

  10. Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder

    Asia-Pacific Psychiatry

    Volume 6, Issue 2, June 2014, Pages: 152–160, Dan Wang, Zexuan Li, Lingjiang Li and Wei Hao

    Version of Record online : 25 FEB 2013, DOI: 10.1111/appy.12060

  11. Does use of tetracyclic antidepressant—mirtazapine reduce cancer risk in depression patients?

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 12, December 2013, Pages: 1292–1297, Li-Min Sun, Ming-Chia Lin, Ji-An Liang, Yen-Jung Chang, Shih-Ni Chang, Fung-Chang Sung, Chih-Hsin Muo and Chia-Hung Kao

    Version of Record online : 20 SEP 2013, DOI: 10.1002/pds.3523

  12. Effects of low-dose mirtazapine on driving performance in healthy volunteers

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 5, September 2013, Pages: 523–528, Kunihiro Iwamoto, Naoko Kawano, Kazumi Sasada, Kunihiro Kohmura, Maeri Yamamoto, Kazutoshi Ebe, Yukihiro Noda and Norio Ozaki

    Version of Record online : 30 JUN 2013, DOI: 10.1002/hup.2327

  13. More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial

    Human Psychopharmacology: Clinical and Experimental

    Volume 25, Issue 6, August 2010, Pages: 431–438, Viacheslav Terevnikov, Jan-Henry Stenberg, Marina Joffe, Jari Tiihonen, Mark Burkin, Evgueni Tchoukhine and Grigori Joffe

    Version of Record online : 18 AUG 2010, DOI: 10.1002/hup.1137

  14. You have free access to this content
    Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain

    Psychiatry and Clinical Neurosciences

    Volume 67, Issue 1, January 2013, Pages: 50–58, Mustafa Gulec, Elif Oral, Onur B. Dursun, Atakan Yucel, Ahmet Hacimuftuoglu, Fatih Akcay and Halis Suleyman

    Version of Record online : 21 DEC 2012, DOI: 10.1111/j.1440-1819.2012.02395.x

  15. You have free access to this content
    Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression

    Psychiatry and Clinical Neurosciences

    Volume 62, Issue 1, February 2008, Pages: 75–83, Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Young-Chul Kim, Kyu-Sik Kim, Ki-Min Kim, Su-Jin Yang and Jin-Sang Yoon

    Version of Record online : 13 FEB 2008, DOI: 10.1111/j.1440-1819.2007.01778.x

  16. Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 34, Issue 4, August 2011, Pages: 388–396, J. M. QUIMBY, D. L. GUSTAFSON, B. J. SAMBER and K. F. LUNN

    Version of Record online : 24 OCT 2010, DOI: 10.1111/j.1365-2885.2010.01244.x

  17. Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache

    European Journal of Neurology

    Volume 14, Issue 2, February 2007, Pages: 187–193, L. Bendtsen, L. Buchgreitz, S. Ashina and R. Jensen

    Version of Record online : 23 JAN 2007, DOI: 10.1111/j.1468-1331.2006.01607.x

  18. Mechanism of action of mirtazapine: dual action or dual effect?

    Australian and New Zealand Journal of Psychiatry

    Volume 38, Issue 4, April 2004, Pages: 267–269, Trevor R. Norman

    Version of Record online : 22 MAR 2004, DOI: 10.1111/j.1440-1614.2004.01348.x

  19. Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase

    Human Psychopharmacology: Clinical and Experimental

    Volume 26, Issue 3, April 2011, Pages: 188–193, Viacheslav Terevnikov, Jan-Henry Stenberg, Jari Tiihonen, Marina Joffe, Mark Burkin, Evgueni Tchoukhine and Grigori Joffe

    Version of Record online : 6 APR 2011, DOI: 10.1002/hup.1189

  20. The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression

    American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

    Volume 144B, Issue 3, 5 April 2007, Pages: 325–331, André Tadić, Matthias J. Müller, Dan Rujescu, Ralf Kohnen, Hans H. Stassen, Norbert Dahmen and Armin Szegedi

    Version of Record online : 27 DEC 2006, DOI: 10.1002/ajmg.b.30462